Brief: Solvay Receives Approval For PROXITANE® AHC Against COVID-19
April 24 (Reuters) - SOLVAC SA SOAC.BR :
* RECEIVES APPROVAL TO USE PROXITANE® AHC AGAINST COVID-19
* IT HAS BEEN ADDED TO THE LIST OF DISINFECTANTS FOR USE
AGAINST
SARS-COV-2
Source text: https://bit.ly/3cCbRy2
Further company coverage: SOAC.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Solvac SA
See all newsBrief: Solvac Monitoring Market-Related Situation With Syensqo's Board
KBC cuts Solvac on structural hurdles despite wide discount
Brief: Solvac To Pay New Interim Dividend Of EUR 1.48 Gross Per Share On January 30, 2025
Brief: Solvay Signs Supply Agreement With Cyclic Materials
Brief: Solvay Completes EUR 1.5 Billion Dual Tranche Bond Issuance